Sematid Tablet 3 mg contains Semaglutide, an oral antidiabetic medicine used for the management of type 2 diabetes mellitus. Semaglutide belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists) that help improve blood sugar control by enhancing insulin secretion and reducing glucagon release in a glucose-dependent manner.

Sematid Tablet 3 mg is typically used as an initial starting dose to help the body adjust to therapy before increasing to higher maintenance doses as recommended by a physician. It works by stimulating insulin release when blood glucose levels are elevated, slowing gastric emptying, and promoting a feeling of fullness, which may also support weight management in patients with type 2 diabetes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Sematid Tablet 3 mg is indicated for:

• Management of type 2 diabetes mellitus in adults

• Improvement of glycemic control as an adjunct to diet and exercise

• Patients who require better blood sugar regulation when lifestyle modifications alone are insufficient

It may be used alone or in combination with other antidiabetic medications as advised by a healthcare professional.

Mechanism of Action

Semaglutide mimics the action of the natural GLP-1 hormone. It:

• Increases insulin secretion in response to elevated blood glucose

• Decreases glucagon secretion

• Slows gastric emptying

• Helps reduce appetite

These combined effects lead to improved blood glucose control and may contribute to gradual weight reduction in some patients.

Dosage and Administration

Sematid Tablet 3 mg is usually taken once daily, preferably in the morning, on an empty stomach. It should be taken with a small amount of plain water (no more than 120 ml), at least 30 minutes before the first food, beverage, or other oral medications of the day.

The tablet should be swallowed whole without crushing or chewing. After 30 days on the 3 mg dose, the physician may increase the dose depending on treatment response and tolerability.

Precautions and Warnings

• Not indicated for type 1 diabetes mellitus or diabetic ketoacidosis.

• Use with caution in patients with a history of pancreatitis.

• Gastrointestinal side effects are common during initiation.

• Monitor blood glucose regularly as directed by a healthcare provider.

• Inform the doctor about any other medications to avoid interactions.

Pregnant or breastfeeding women should consult a physician before use.

Side Effects

Common side effects may include:

• Nausea

• Vomiting

• Diarrhea

• Abdominal pain

• Decreased appetite

These effects are usually mild to moderate and tend to decrease over time. Seek medical attention if severe or persistent symptoms occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Sematid Tablet 3 mg provides an effective oral option for initiating GLP-1 receptor agonist therapy, supporting improved glycemic control and better metabolic outcomes when used under medical supervision.